Abound Health Acquires Heartspring in Significant IDD Service Expansion
Deal News | Jun 04, 2025 | TT Capital Partners LLC
The latest edition of TripleTree's Healthcare M&A Weekly outlines pivotal transactions in the healthcare industry as of June 4, 2025. This summary highlights the dynamic interplay between healthcare technology and services, reinforcing ongoing innovation and transformation across the sector. Significant acquisitions include Abound Health's procurement of Heartspring, and Active Day's acquisition of PremierCare Consulting. Funding rounds attract attention with Acclaro Medical raising $23M and GRIN Therapeutics securing $140M. High-profile deals such as GTCR's sale of Antylia Scientific for $1.34B to Brookfield Asset Management and CDPQ, and Eli Lilly's acquisition of SiteOne Therapeutics underscore the sector's vibrancy. Finance experts note that the summary reflects a spectrum of investment activities signaling growth and evolution in healthcare.
Sectors
- Healthcare Services
- Healthcare Technology
- Biotechnology
- Private Equity
Geography
- United States – The article predominantly discusses companies and transactions within the U.S., including entities like ChristianaCare and MDaudit.
Industry
- Healthcare Services – This involves sectors such as urgent care, IDD services, and integrated senior care, highlighted by transactions like Abound Health's acquisition of Heartspring.
- Healthcare Technology – Includes entities like John Snow Labs and Ascend Learning, reflecting the growing intersection of tech and medical services through acquisitions and mergers.
- Biotechnology – The involvement of companies like GRIN Therapeutics and Vima Therapeutics indicates substantial investment and M&A activity within the biotech sector.
- Private Equity – The role of firms like Coalesce Capital in acquiring DAS Health and GTCR in selling Antylia Scientific demonstrates the private equity landscape's engagement in healthcare.
Financials
- $1.34B – The sale price of Antylia Scientific to Brookfield Asset Management and CDPQ.
- $23M – Series B funding amount raised by Acclaro Medical.
- $140M – Series D funding secured by GRIN Therapeutics.
- $60M – Series A funding raised by Vima Therapeutics.
- $37.4M – Valuation of the all-cash transaction for MDaudit's merger with Streamline Health.
- $100M – Equity investment by MidOcean Partners in Emergency Care Partners.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Abound Health | Acquirer | Company | Provider of IDD services that acquired Heartspring. |
| Heartspring | Target Company | Company | A provider of mental health and IDD services acquired by Abound Health. |
| Active Day | Acquirer | Company | Provider of IDD services that acquired PremierCare Consulting. |
| PremierCare Consulting | Target Company | Company | Provider of planning and case management services for IDD clinicians acquired by Active Day. |
| GTCR | Seller | Company | Private equity firm that sold Antylia Scientific. |
| Brookfield Asset Management | Acquirer | Company | Company acquiring Antylia Scientific, alongside CDPQ. |
| CDPQ | Acquirer | Company | Acquired Antylia Scientific with Brookfield Asset Management. |
| Accelmed Partners | Investor | Company | Led the Series B funding round for Acclaro Medical. |
| Acclaro Medical | Funded Company | Company | Raised $23M in Series B funding. |